Table 3.
Right liver resection | |||
---|---|---|---|
One-stage procedure n = 163 | Two-stage procedure n = 35 | ||
Post-operative complications overalla (incl. mortality during hospitalization) | 106 | 25 | |
Post-operative complicationsa | |||
– None | 57 | 10 | |
– Grade I | 31 | 7 | |
– Grade II | 28 | 9 | |
– Grade IIIA | 22 | 3 | |
– Grade IIIB | 9 | 0 | |
– Grade IVA | 7 | 2 | |
– Grade IVB | 3 | 2 | |
– Grade V (=mortality during hospitalization) | 6 | 2 | |
Severe complications ≥IIIAa | 47 | 9 | |
Post-operative liver failureb | 5 | 1 | |
30 days mortality | 5 | 0 | |
90 days mortality | 9 | 5 | |
AST peak (U/l) | 505 (334–807) | 543 (370–986) | |
ALT peak (U/l) | 461 (306–737) | 476 (293–1030) | |
Bilirubin peak (μmol/l) | 45 (33–63) | 38 (20–63) | |
Creatinine peak (μmol/l) | 82 (68–96) | 79 (69–107) | |
Length of hospital stay (days) | 12 (10–15) | 12 (11–22) | |
Length of special care unit stay (days) | 1 (1–2) | 1 (1–1) |
All results are presented in median and interquartile range.25
Complication classification according to the Clavien–Dindo classification system.
‘Complications ≥ III A’ includes mortality during hospitalization.
Post-operative liver failure as defined by the ‘50-50’ criteria.
AST, aspartate aminotransferase; ALT, alanine aminotransferase.